XML 37 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note 1 - Organization, Basis of Presentation and Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Mar. 01, 2015
USD ($)
May. 31, 2015
USD ($)
$ / shares
shares
May. 25, 2014
USD ($)
$ / shares
shares
May. 26, 2013
USD ($)
$ / shares
shares
Customer Relationships [Member] | Minimum [Member]        
Finite-Lived Intangible Asset, Useful Life   12 years    
Customer Relationships [Member] | Maximum [Member]        
Finite-Lived Intangible Asset, Useful Life   13 years    
Minimum [Member] | Apio [Member]        
Notes and Advances Receivable, Term   90 days    
Minimum [Member] | Buildings and Leasehold Improvements [Member]        
Property, Plant and Equipment, Useful Life   3 years    
Minimum [Member] | Other Capitalized Property Plant and Equipment [Member]        
Property, Plant and Equipment, Useful Life   3 years    
Minimum [Member] | Software Development [Member]        
Property, Plant and Equipment, Useful Life   3 years    
Maximum [Member] | Apio [Member]        
Notes and Advances Receivable, Term   270 days    
Maximum [Member] | Buildings and Leasehold Improvements [Member]        
Property, Plant and Equipment, Useful Life   40 years    
Maximum [Member] | Other Capitalized Property Plant and Equipment [Member]        
Property, Plant and Equipment, Useful Life   20 years    
Maximum [Member] | Software Development [Member]        
Property, Plant and Equipment, Useful Life   7 years    
Apio [Member] | Apio Cooling, LP [Member]        
Investment Ownership Percentage   60.00%    
Apio [Member]        
Notes and Advances Receivable   $ 0    
Apio Cooling, LP [Member]        
Stockholders' Equity Attributable to Noncontrolling Interest   $ 1,700,000 $ 1,700,000  
Business Acquisition, Percentage of Voting Interests Acquired   60.00%    
Aesthetic Sciences [Member]        
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net $ 793,000      
Windset [Member] | Cost of Sales [Member]        
Revenue from Related Parties   $ 537,000 365,000 $ 316,000
Related Party Costs   1,600,000 1,600,000 2,100,000
Windset [Member] | Accounts Receivable, Related Parties [Member]        
Accounts Receivable, Related Parties, Current   306,000 304,000  
Windset [Member] | Accounts Payable, Related Parties [Member]        
Accounts Payable, Related Parties   $ 244,000 $ 134,000  
Windset [Member]        
Investment Ownership Percentage   26.90% 20.10%  
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Costco and Wal-mart [Member]        
Number of Major Customers   2 2  
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Costco [Member]        
Concentration Risk, Percentage   21.00% 21.00%  
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Wal-mart [Member]        
Concentration Risk, Percentage   11.00% 11.00%  
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | International Customers [Member]        
Concentration Risk, Percentage   30.00% 29.00%  
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]        
Number of Major Customers   5 5  
Concentration Risk, Percentage   46.00% 42.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Costco and Wal-mart [Member]        
Number of Major Customers     2  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Costco [Member]        
Concentration Risk, Percentage   15.00% 16.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Wal-mart [Member]        
Concentration Risk, Percentage   13.00% 12.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member]        
Number of Major Customers   2    
Product Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | HA Based Biomaterials [Member] | Ophthalmic [Member]        
Concentration Risk, Percentage   60.00%    
Product Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | HA Based Biomaterials [Member] | Orthopedic [Member]        
Concentration Risk, Percentage   20.00%    
HA Based Biomaterials [Member]        
Number of Product Segments   3    
Goodwill   $ 13,900,000 $ 13,900,000 13,900,000
Food Products Technology [Member]        
Goodwill   35,700,000 35,700,000 35,700,000
Goodwill, Impairment Loss   0 0 0
Stockholders' Equity Attributable to Noncontrolling Interest   $ 1,677,000 1,692,000  
Number of Proprietary Platforms   2    
Advertising Expense   $ 1,300,000 447,000 445,000
Accounts Receivable, Related Parties, Current   306,000 304,000  
Capitalized Computer Software, Additions   509,000 913,000 $ 0
Goodwill   49,620,000 $ 49,620,000  
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net   793,000    
Deferred Revenue   843,000 $ 1,300,000  
Deferred Tax Assets, Valuation Allowance   $ 1,234,000 $ 881,000  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares   371,115 333,993 88,022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares   $ 14.02 $ 14.15 $ 12.80
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 3.42 $ 4.41 $ 3.57